Abstract
Recent decisions regarding hormone-replacement therapy/estrogen-replacement therapy as well as its association with breast cancer have caused confusion for practitioners. This article attempts to elucidate recent controversies and provides a critical review of recent publications. While low-dose hormone-replacement therapy seems to be a reasonable option for symptomatic postmenopausal women, they should be counseled properly regarding their risk of developing or suffering a recurrence of breast cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
